Drugs / CITATUZUMAB BOGATOX
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT00481936 | May 2007 → Apr 2008 | epithelial neoplasm | Sesen Bio, Inc. | Terminated | No outcome recorded |
Evidence & citations 5 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | CITATUZUMAB BOGATOX | ChEMBL registry synonym — accepted as the source's own label CHEMBL1743000 ↗ |
| Known as | VB6-845 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00481936 ↗ |
| Modality | Protein / enzyme biologic | “a Recombinant Fusion Protein Targeting EpCAM” NCT00481936 ↗ |
| Route | Intravenous | “administered as a monotherapy IV infusion” NCT00481936 ↗ |
| Target | EPCAM | “Epithelial cell adhesion molecule binding agent” CHEMBL1743000 ↗ |